Market tearaway Clarity Pharmaceuticals is preparing to launch its biggest-ever capital raising as early as Monday.
The clinical-stage $1.3 billion company is pioneering new cancer treatments using copper radioisotopes, which it hopes will be on the market in the next two years.
Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Connect with Emma on Twitter. Email Emma at emma.rapaport@afr.com
